Skip to content

Preliminary clinical study of phacoemulsification combined with trifocal intraocular lens implantation in presbyopia patients with early cataract

Preliminary clinical study of phacoemulsification combined with trifocal intraocular lens implantation in presbyopia patients with early cataract

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052414
Enrollment
Unknown
Registered
2021-10-25
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trifoci intraocular lens

Interventions

Group A:Acry IQ PanOptix was implanted in both eyes
Group B:ATLisa tri839MP IOL implanted in both eyes

Sponsors

Chongqing Aier Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Gender is not limited, age 40 to 80 years old; 2. Early-stage simple age-related cataract patients with best corrected visual acuity >=0.5, eye axis <28.0mm, preoperative regular corneal astigmatism <1.0D, DLI (Dysfunctional Lens Index) <=5; 3. The diameter of the natural pupil in the dark room is 3.0-5.0mm; the Kappa angle is less than 0.5mm or the Kappa is less than half of the diameter of the MIOL central large optical zone; 4. The patient hopes to reduce the dependence on the glasses after surgery, and has certain requirements for the distance, middle and near vision; 5. There is no active inflammation and no progressive fundus disease in the eyes.

Exclusion criteria

Exclusion criteria: 1. Have a history of intraocular surgery and refractive surgery; 2. Combined with serious primary diseases such as serious cardiovascular and cerebrovascular, liver, kidney and hematopoietic system; 3. Those who have undergone intraocular surgery or eye trauma within the past six months; 4. Treatments that may affect the outcome; 5. Paranoid and perfectionist; 6. Intraoperative posterior capsule rupture, intraocular lens suture, intraocular hemorrhage, etc.; 7. Those who do not cooperate with the postoperative examination.

Design outcomes

Primary

MeasureTime frame
visual acuity,;refraction;defocus curves;contrast sensitivitv;

Countries

China

Contacts

Public ContactWu Ping

Chongqing Aier Eye Hospital

729181612@qq.com+86 13883206312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026